Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지

Comparisons of Perception on Direct-to-Consumer Advertisements of Prescription Drugs between Healthcare Providers and Consumers

전문의약품 대중광고에 대한 의약전문인과 일반인간의 인식 비교 연구

  • Oh, Jiwun (Graduate School of Clinical Health Sciences, Ewha Womans University) ;
  • Kim, Kitai (Department of Communication, Honam University) ;
  • An, Sook Hee (College of Pharmacy, Wonkwang University) ;
  • Gwak, Hye Sun (Graduate School of Clinical Health Sciences, Ewha Womans University)
  • 오지운 (이화여자대학교 임상보건과학대학원) ;
  • 김기태 (호남대학교 신문방송학과) ;
  • 안숙희 (원광대학교 약학대학) ;
  • 곽혜선 (이화여자대학교 임상보건과학대학원)
  • Received : 2014.08.25
  • Accepted : 2015.02.26
  • Published : 2015.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: The aim of this study was to investigate the difference of perception on direct-to-consumer advertisement (DTCA) of prescription drugs between healthcare providers and consumers. Methods: The online and offline survey was conducted from May 26th to June 5th, 2013. The questionnaire was composed of 15 items about perception on DTCA of prescription drugs. Results: A total of 215 healthcare providers and 202 consumers responded to the questionnaire. Consumers had an overall positive attitude on permitting DTCA of prescription drugs and carried favorable views about the influence of the DTCA of prescription drugs on providing drug information, promoting communications between healthcare providers and consumers, and improving images of healthcare providers. Healthcare providers displayed negative perception for the needs of permitting the DTCA of prescription drugs compared to consumers. They showed somewhat skeptical perception about the influence of the DTCA of prescription drugs on necessities and efficiencies of delivering drug information, promoting communications between healthcare providers and consumers, and improving images of healthcare providers. Both healthcare providers and consumers were concerned about the increase of drug prices following the increase in advertisement expenses of pharmaceutical products. Conclusion: This study identified the perception differences on direct-to-consumer advertisements of prescription drugs between healthcare providers and consumers. This study could be of much help in the process of review on permitting DTCA of prescription drugs in Korea.

Keywords

References

  1. Donohue JM, Cevasco M, Rosenthal MB. A decade of direct-to-consumer advertising of prescription drugs. N Engl J Med 2007; 357(7):673-81. https://doi.org/10.1056/NEJMsa070502
  2. Norey E, Simone TM, Mousa SA. The impact of direct-to-consumer advertised drugs on drug sales in the US and New Zealand. Appl Health Econ Health Policy 2008;6(2-3):93-102. https://doi.org/10.1007/BF03256125
  3. Mintzes B, Morgan S, Wright JM. Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale. PLoS One. 2009;4(5):e5699. https://doi.org/10.1371/journal.pone.0005699
  4. H. C. Kang. Study on Discussion for Deregulation of Direct-to-Consumer Advertising of Ethical Drugs -Focusing on Cases of the United States, Canada and the European Union-. The Yonsei Law Review 2013;23(2):179-214.
  5. The rules on the safety of drugs [Trial 2013, 3, 23] [Sub-Decree No. 1022, enacted 23/03/2013]
  6. Digital BOSA, July 19, 2012.
  7. Yakup Daily, May 23, 2012.
  8. Kukminilbo, June 8, 2011.
  9. Hankookilbo, May 5, 2014.
  10. Etoday, Feb 3, 2012.
  11. Healthkoreanews, July 1, 2008.
  12. Yakup Daily, Dec 17, 2010.
  13. Hankyung, Jan 12, 2011.
  14. Liu Y, Doucette WR. Does direct-to-consumer advertising affect patients' choice of pain medications? Curr Pain Headache Rep 2008; 12(2):89-93. https://doi.org/10.1007/s11916-008-0017-2
  15. Block AE. Costs and benefits of direct-to-consumer advertising: the case of depression. Pharmacoeconomics 2007;25(6):511-21. https://doi.org/10.2165/00019053-200725060-00006
  16. Abel GA, Chen K, Taback N, et al. Impact of oncology-related directto-consumer advertising: association with appropriate and inappropriate prescriptions. Cancer 2013;119(5): 1065-72. https://doi.org/10.1002/cncr.27814
  17. Datti B, Carter MW. The effect of direct-to-consumer advertising on prescription drug use by older adults. Drugs Aging 2006;23(1):71-81. https://doi.org/10.2165/00002512-200623010-00007
  18. Martinez LS, Lewis N. The role of direct-to-consumer advertising in shaping public opinion surrounding prescription drug use to treat depression or anxiety in youth. J Health Commun 2009;14(3):246-61. https://doi.org/10.1080/10810730902805820
  19. Murray E, Lo B, Pollack L, et al. Direct-to-consumer advertising: physicians' views of its effects on quality of care and the doctor-patient relationship. J Am Board Fam Pract 2003;16(6):513-24. https://doi.org/10.3122/jabfm.16.6.513
  20. Chaar B, Kwong K. Direct-to-consumer advertising: Australian pharmacists' experiences with non-prescription medicines. Int J Pharm Pract 2010;18(1):43-50. https://doi.org/10.1211/ijpp.18.01.0008
  21. Desselle SP, Aparasu R. Attitudinal dimensions that determine pharmacists' decisions to support DTCA of prescription medication. Drug information Journal 2000;34:103-114. https://doi.org/10.1177/009286150003400114
  22. Suh HS, Lee D, Kim SY, et al. Direct-to-consumer advertising (DTCA) for prescription drugs: consumers' attitudes and preferences concerning its regulation in South Korea. Health Policy 2011;101(3):260-8. https://doi.org/10.1016/j.healthpol.2011.05.005
  23. Harrington AR, Desselle SP, Apgar DA, et al. Pharmacy student's opinions of direct-to-consumer advertising: A pilot study one university. Res Social Adm Pharm 2013;9(4):458-66. https://doi.org/10.1016/j.sapharm.2012.07.005